AptarGroup, Inc. - stock earnings
ATR Upcoming estimated earnings
Date | Actual / Estimated EPS | Low Revenue | Actual / Estimated Revenue | High Revenue |
---|---|---|---|---|
April 25, 2024 AfterMarket | - / 1.1575000000 | 878.6 million | - / 899.2 million | 913.0 million |
ATR Quarterly earnings
Date | Earnings | Revenue |
---|---|---|
2023Q4 | 62.4 million USD | 838.5 million USD |
2023Q3 | 84.3 million USD | 893.0 million USD |
2023Q2 | 83.1 million USD | 895.9 million USD |
2023Q1 | 54.8 million USD | 860.1 million USD |
2022Q4 | 59.0 million USD | 795.9 million USD |
2022Q3 | 54.2 million USD | 836.9 million USD |
2022Q2 | 63.6 million USD | 844.5 million USD |
2022Q1 | 62.4 million USD | 844.9 million USD |
2021Q4 | 57.6 million USD | 814.0 million USD |
2021Q3 | 47.3 million USD | 825.4 million USD |
2021Q2 | 55.3 million USD | 811.0 million USD |
2021Q1 | 84.0 million USD | 776.8 million USD |
2020Q4 | 53.2 million USD | 749.3 million USD |
2020Q3 | 63.7 million USD | 759.2 million USD |
2020Q2 | 41.8 million USD | 699.3 million USD |
2020Q1 | 55.3 million USD | 721.6 million USD |
2019Q4 | 48.5 million USD | 671.3 million USD |
2019Q3 | 56.8 million USD | 701.3 million USD |
2019Q2 | 73.9 million USD | 742.7 million USD |
2019Q1 | 63.0 million USD | 744.5 million USD |
2018Q4 | 40.7 million USD | 685.0 million USD |
2018Q3 | 39.0 million USD | 665.8 million USD |
2018Q2 | 55.8 million USD | 710.6 million USD |
2018Q1 | 59.3 million USD | 703.4 million USD |
2017Q4 | 49.5 million USD | 625.9 million USD |
2017Q3 | 53.5 million USD | 624.3 million USD |
2017Q2 | 65.2 million USD | 617.7 million USD |
2017Q1 | 51.8 million USD | 601.3 million USD |
2016Q4 | 49.6 million USD | 538.9 million USD |
2016Q3 | 53.1 million USD | 589.7 million USD |
2016Q2 | 59.0 million USD | 620.0 million USD |
2016Q1 | 43.9 million USD | 582.3 million USD |
2015Q4 | 43.4 million USD | 546.8 million USD |
2015Q3 | 53.2 million USD | 586.3 million USD |
2015Q2 | 57.5 million USD | 594.3 million USD |
2015Q1 | 45.2 million USD | 589.8 million USD |
2014Q4 | 41.6 million USD | 599.2 million USD |
2014Q3 | 48.6 million USD | 651.9 million USD |
2014Q2 | 53.1 million USD | 670.6 million USD |
2014Q1 | 48.4 million USD | 676.1 million USD |
2013Q4 | 36.9 million USD | 637.3 million USD |
2013Q3 | 45.3 million USD | 623.6 million USD |
2013Q2 | 49.8 million USD | 641.4 million USD |
2013Q1 | 40.0 million USD | 617.6 million USD |
2012Q4 | 35.0 million USD | 571.4 million USD |
2012Q3 | 42.1 million USD | 589.6 million USD |
2012Q2 | 41.7 million USD | 577.5 million USD |
2012Q1 | 43.8 million USD | 592.5 million USD |
2011Q4 | 38.6 million USD | 544.5 million USD |
2011Q3 | 49.3 million USD | 601.2 million USD |
2011Q2 | 51.3 million USD | 614.9 million USD |
2011Q1 | 39.0 million USD | 505.5 million USD |
2010Q4 | 40.8 million USD | 530.8 million USD |
2010Q3 | 47.0 million USD | 517.5 million USD |
2010Q2 | 46.7 million USD | 522.9 million USD |
2010Q1 | 39.0 million USD | 505.5 million USD |
2009Q4 | 36.0 million USD | 495.6 million USD |
2009Q3 | 33.5 million USD | 473.7 million USD |
2009Q2 | 28.5 million USD | 440.5 million USD |
2009Q1 | 26.7 million USD | 431.8 million USD |
2008Q4 | 31.7 million USD | 455.9 million USD |
2008Q3 | 39.7 million USD | 532.2 million USD |
2008Q2 | 45.3 million USD | 551.3 million USD |
2008Q1 | 36.9 million USD | 532.3 million USD |
2007Q4 | 35.8 million USD | 483.8 million USD |
2007Q3 | 39.4 million USD | 485.7 million USD |
2007Q2 | 37.0 million USD | 472.9 million USD |
2007Q1 | 29.6 million USD | 449.8 million USD |
2006Q4 | 27.2 million USD | 422.4 million USD |
2006Q3 | 28.2 million USD | 404.9 million USD |
2006Q2 | 27.7 million USD | 398.6 million USD |
2006Q1 | 19.8 million USD | 375.5 million USD |
2005Q4 | 23.7 million USD | 338.8 million USD |
2005Q3 | 24.9 million USD | 341.1 million USD |
2005Q2 | 29.3 million USD | 356.1 million USD |
2005Q1 | 22.1 million USD | 344.0 million USD |
2004Q4 | 24.0 million USD | 343.3 million USD |
2004Q3 | 25.3 million USD | 325.9 million USD |
2004Q2 | 22.8 million USD | 311.8 million USD |
2004Q1 | 21.2 million USD | 315.6 million USD |
2003Q4 | 20.0 million USD | 280.1 million USD |
2003Q3 | 19.1 million USD | 281.3 million USD |
2003Q2 | 21.3 million USD | 288.1 million USD |
2003Q1 | 19.2 million USD | 265.1 million USD |
2002Q4 | 18.1 million USD | 235.1 million USD |
2002Q3 | 17.8 million USD | 239.8 million USD |
2002Q2 | 17.5 million USD | 233.2 million USD |
2002Q1 | 13.3 million USD | 218.7 million USD |
2001Q4 | 9.8 million USD | 205.7 million USD |
2001Q3 | 15.7 million USD | 221.6 million USD |
2001Q2 | 15.2 million USD | 231.8 million USD |
2001Q1 | 18.1 million USD | 233.8 million USD |
2000Q4 | 14.4 million USD | 213.5 million USD |
2000Q3 | 16.2 million USD | 224.7 million USD |
2000Q2 | 17.8 million USD | 227.7 million USD |
2000Q1 | 16.3 million USD | 217.6 million USD |
1999Q4 | 15.4 million USD | 216.7 million USD |
1999Q3 | 12.9 million USD | 210.5 million USD |
1999Q2 | 16.2 million USD | 208.9 million USD |
1999Q1 | 14.3 million USD | 198.2 million USD |
1998Q4 | 18.8 million USD | 178.1 million USD |
1998Q3 | 14.5 million USD | 182.7 million USD |
1998Q2 | 14.3 million USD | 181.8 million USD |
1998Q1 | 13.2 million USD | 170.9 million USD |
1997Q4 | 10.5 million USD | 161.8 million USD |
1997Q3 | 12.5 million USD | 163.5 million USD |
1997Q2 | 12.1 million USD | 171.8 million USD |
1997Q1 | 11.4 million USD | 158.3 million USD |
1996Q4 | 9.0 million USD | 155.9 million USD |
1996Q3 | 9.0 million USD | 155.9 million USD |
1996Q2 | 8.8 million USD | 151.0 million USD |
1996Q1 | 10.7 million USD | 153.0 million USD |
1995Q4 | 7.7 million USD | 138.8 million USD |
1995Q3 | 8.5 million USD | 140.6 million USD |
1995Q2 | 9.9 million USD | 142.4 million USD |
1995Q1 | 9.6 million USD | 135.6 million USD |
1994Q4 | 6.2 million USD | 118.9 million USD |
1994Q3 | 6.3 million USD | 119.9 million USD |
1994Q2 | 7.5 million USD | 118.2 million USD |
1994Q1 | 7.2 million USD | 117.2 million USD |
1993Q4 | 4.3 million USD | 103.4 million USD |
1993Q3 | 5.1 million USD | 105.0 million USD |
1993Q2 | 6.1 million USD | 107.9 million USD |
1993Q1 | 7.4 million USD | 95.2 million USD |
1992Q4 | 3.7 million USD | 93.5 million USD |
1992Q3 | 4.8 million USD | 93.2 million USD |
1992Q2 | 5.8 million USD | 92.1 million USD |
1992Q1 | 5.3 million USD | 91.6 million USD |
ATR Yearly earnings
Date | Earnings | Revenue |
---|---|---|
2023 | 284.5 million USD | 3.5 billion USD |
2022 | 239.3 million USD | 3.3 billion USD |
2021 | 244.1 million USD | 3.2 billion USD |
2020 | 214.0 million USD | 2.9 billion USD |
2019 | 242.2 million USD | 2.9 billion USD |
2018 | 194.7 million USD | 2.8 billion USD |
2017 | 220.0 million USD | 2.5 billion USD |
2016 | 205.6 million USD | 2.3 billion USD |
2015 | 199.3 million USD | 2.3 billion USD |
2014 | 191.7 million USD | 2.6 billion USD |
2013 | 172.0 million USD | 2.5 billion USD |
2012 | 162.6 million USD | 2.3 billion USD |
2011 | 183.7 million USD | 2.3 billion USD |
2010 | 173.5 million USD | 2.1 billion USD |
2009 | 124.6 million USD | 1.8 billion USD |
2008 | 153.5 million USD | 2.1 billion USD |
2007 | 141.7 million USD | 1.9 billion USD |
2006 | 102.9 million USD | 1.6 billion USD |
2005 | 100.0 million USD | 1.4 billion USD |
2004 | 93.3 million USD | 1.3 billion USD |
2003 | 79.7 million USD | 1.1 billion USD |
2002 | 66.6 million USD | 926.7 million USD |
2001 | 58.8 million USD | 892.0 million USD |
2000 | 64.7 million USD | 883.5 million USD |
1999 | 58.7 million USD | 834.3 million USD |
1998 | 60.8 million USD | 713.5 million USD |
1997 | 46.5 million USD | 655.4 million USD |
1996 | 37.5 million USD | 615.8 million USD |
1995 | 35.7 million USD | 557.5 million USD |
1994 | 27.3 million USD | 474.3 million USD |
1993 | 23.0 million USD | 411.5 million USD |
1992 | 19.5 million USD | 370.3 million USD |
ATR
List: Champions
Price: $140.95
Dividend Yield: 0.01%
Forward Dividend Yield: 1.17%
Payout Ratio: 38.59%
Dividend Per Share: 1.64 USD
Earnings Per Share: 4.25 USD
P/E Ratio: 32.35
Exchange: NYQ
Sector: Healthcare
Industry: Medical Instruments & Supplies
Volume: 284100
Ebitda: 129.6 millionMarket Capitalization: 9.2 billion
Average Dividend Frequency: 4
Years Paying Dividends: 32
DGR3: -6.50%
DGR5: -0.40%
DGR10: 3.75%
DGR20: 14.71%